Expression of the P16 Protein in Serous Papillary Endometrial Cancer, and Its Clinical and Prognostic Significance
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Female
Serous Papillary Endometrial Cancer
Female
Serous Papillary Endometrial Cancer
Trial Information
Expression of the P16 Protein in Serous Papillary Endometrial Cancer, and Its Clinical and Prognostic Significance
Inclusion Criteria:
- diagnosis of endometrial cancer
- histology block exists in hospital's library
Exclusion Criteria:
- none
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Retrospective
Outcome Measure:
Overall survival
Outcome Time Frame:
last followup (2-10 years)
Safety Issue:
No
Authority:
Israel: Ministry of Health
Study ID:
230CTIL
NCT ID:
NCT01267357
Start Date:
July 2010
Completion Date:
Related Keywords:
- Serous Papillary Endometrial Cancer
- Serous Papillary Endometrial Cancer
- Endometrioid endometrial cancer
- biomarkers
- P16
- P53
- Prognosis
- Endometrial Neoplasms
- Sarcoma, Endometrial Stromal
- Adenoma
Name | Location |
|---|
